Next Article in Journal
Beta-Caryophyllene Exhibits Anti-Proliferative Effects through Apoptosis Induction and Cell Cycle Modulation in Multiple Myeloma Cells
Next Article in Special Issue
EWSR1-WT1 Target Genes and Therapeutic Options Identified in a Novel DSRCT In Vitro Model
Previous Article in Journal
Risk of Malignant Transformation in 3173 Subjects with Histopathologically Confirmed Oral Lichen Planus: A 33-Year Cohort Study in Northern Italy
Previous Article in Special Issue
Characteristics of Nephroblastoma/Nephroblastomatosis in Children with a Clinically Reported Underlying Malformation or Cancer Predisposition Syndrome
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Welter et al. Characteristics of Nephroblastoma/Nephroblastomatosis in Children with a Clinically Reported Underlying Malformation or Cancer Predisposition Syndrome. Cancers 2021, 13, 5016

1
Department of Pediatric Oncology and Hematology, Saarland University, 66421 Homburg, Germany
2
Department of Radiation Oncology, Saarland University, 66421 Homburg, Germany
3
St. Anna Kinderspital, Department of Pediatrics, Medical University Vienna, Kinderspitalgasse 6, 1090 Vienna, Austria
4
Section of Pediatric Pathology, University of Bonn, Venusberg-Campus 1, 53127 Bonn, Germany
5
Division of Pediatric Radiology, Clinic for Diagnostic and Interventional Radiology, University of Heidelberg, Im Neuenheimer Feld 430, 69120 Heidelberg, Germany
6
Department of General, Visceral, Vascular and Pediatric Surgery, Saarland University, 66421 Homburg, Germany
7
Department of Urology and Pediatric Urology, Saarland University, 66421 Homburg, Germany
8
Developmental Biochemistry and Comprehensive Cancer Center Mainfranken, Theodor-Boveri-Institute/Biocenter, University of Würzburg, 97074 Würzburg, Germany
*
Author to whom correspondence should be addressed.
Cancers 2021, 13(22), 5743; https://doi.org/10.3390/cancers13225743
Submission received: 1 November 2021 / Accepted: 12 November 2021 / Published: 16 November 2021
(This article belongs to the Special Issue Pediatric Cancers)
In the original article [1] there was a mistake in Table 2 as published. Table 2 contains wrong percentages in lines Bilateral disease and Patients with CPS or GU. For this reason the table should be replaced with the correct one as shown below.
The authors apologize for any inconvenience caused and state that the scientific conclusions are unaffected. The original article has been updated.

Reference

  1. Welter, N.; Wagner, A.; Furtwängler, R.; Melchior, P.; Kager, L.; Vokuhl, C.; Schenk, J.-P.; Meier, C.M.; Siemer, S.; Gessler, M.; et al. Characteristics of Nephroblastoma/Nephroblastomatosis in Children with a Clinically Reported Underlying Malformation or Cancer Predisposition Syndrome. Cancers 2021, 13, 5016. [Google Scholar] [CrossRef] [PubMed]
Table 2. Association between nephroblastomatosis (NBL) and CPS or malformation in the whole cohort of patients and bilateral disease; * chi-square p ≤ 0.001. WT: Wilms tumor; CPS: cancer predisposition syndrome; NBL: nephroblastomatosis; GU: Genitourinary malformations; BWS: Beckwith-Wiedemann spectrum; IHH: isolated hemihypertrophy; DDS: Denys-Drash syndrome; WAGR: Wilms tumor, aniridia, genitourinary abnormalities, range of developmental delays.
Table 2. Association between nephroblastomatosis (NBL) and CPS or malformation in the whole cohort of patients and bilateral disease; * chi-square p ≤ 0.001. WT: Wilms tumor; CPS: cancer predisposition syndrome; NBL: nephroblastomatosis; GU: Genitourinary malformations; BWS: Beckwith-Wiedemann spectrum; IHH: isolated hemihypertrophy; DDS: Denys-Drash syndrome; WAGR: Wilms tumor, aniridia, genitourinary abnormalities, range of developmental delays.
Isolated NBLWT + NBLWT OnlyTotal
Total732.5%642.2%279095.3%2927100%
Bilateral disease3112.3%6124.1%16163.6%253100%
Patients with CPS or GU22 *12.9% *116.4%13880.7%171100%
Patients without CPS or GU511.9%531.9%265296.2%2756100%
WAGR7 *35.0% *210.0%1155.0%20100%
BWS7 *21.9% *39.4%2268.8%32100%
IHH5 *17.2% *00.0%2482.8%29100%
DDS14.2%28.3%2187.5%24100%
GU23.0%46.1%6090.9%66100%
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Welter, N.; Wagner, A.; Furtwängler, R.; Melchior, P.; Kager, L.; Vokuhl, C.; Schenk, J.-P.; Meier, C.M.; Siemer, S.; Gessler, M.; et al. Correction: Welter et al. Characteristics of Nephroblastoma/Nephroblastomatosis in Children with a Clinically Reported Underlying Malformation or Cancer Predisposition Syndrome. Cancers 2021, 13, 5016. Cancers 2021, 13, 5743. https://doi.org/10.3390/cancers13225743

AMA Style

Welter N, Wagner A, Furtwängler R, Melchior P, Kager L, Vokuhl C, Schenk J-P, Meier CM, Siemer S, Gessler M, et al. Correction: Welter et al. Characteristics of Nephroblastoma/Nephroblastomatosis in Children with a Clinically Reported Underlying Malformation or Cancer Predisposition Syndrome. Cancers 2021, 13, 5016. Cancers. 2021; 13(22):5743. https://doi.org/10.3390/cancers13225743

Chicago/Turabian Style

Welter, Nils, Angelo Wagner, Rhoikos Furtwängler, Patrick Melchior, Leo Kager, Christian Vokuhl, Jens-Peter Schenk, Clemens Magnus Meier, Stefan Siemer, Manfred Gessler, and et al. 2021. "Correction: Welter et al. Characteristics of Nephroblastoma/Nephroblastomatosis in Children with a Clinically Reported Underlying Malformation or Cancer Predisposition Syndrome. Cancers 2021, 13, 5016" Cancers 13, no. 22: 5743. https://doi.org/10.3390/cancers13225743

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop